Recombinant vaccinia viruses are extremely valuable tools for research in m
olecular biology and immunology. The extension of vaccinia vector technolog
y to replication deficient and safety-tested virus strains such as modified
vaccinia virus Ankara (MVA) have made this versatile eukaryotic expression
system even more attractive for basic and clinical research. Here, we repo
rt on easily obtaining recombinant MVA using stringent growth selection on
rabbit kidney RK-13 cells. We describe the construction and use of new MVA
vector plasmids that carry an expression cassette of the vaccinia virus hos
t range gene, KIL, as a transient selectable marker: These plasmids allow e
ither stable insertion of additional recombinant genes into the MVA genome
or precisely targeted mutagenesis of MVA genomic sequences. Repetitive DNA
sequences flanking the KIL gene were designed to remove the marker gene fro
m the viral genome by homologous recombination under nonselective growth co
nditions. The convenience of this new selection technique is demonstrated b
y isolating MVA recombinants that produce green fluorescent protein and by
generating MVA deletion mutants.